Atria Investments Inc Makes New $213,000 Investment in Option Care Health, Inc. (NASDAQ:OPCH)

Atria Investments Inc acquired a new stake in shares of Option Care Health, Inc. (NASDAQ:OPCH) in the 3rd quarter, according to its most recent 13F filing with the SEC. The fund acquired 6,799 shares of the company’s stock, valued at approximately $213,000.

A number of other hedge funds have also recently modified their holdings of the stock. UMB Bank n.a. grew its position in shares of Option Care Health by 937.5% during the 3rd quarter. UMB Bank n.a. now owns 830 shares of the company’s stock valued at $26,000 after acquiring an additional 750 shares during the period. GAMMA Investing LLC boosted its stake in Option Care Health by 110.6% during the 3rd quarter. GAMMA Investing LLC now owns 897 shares of the company’s stock worth $28,000 after purchasing an additional 471 shares during the last quarter. Whittier Trust Co. of Nevada Inc. increased its holdings in shares of Option Care Health by 3,362.8% in the third quarter. Whittier Trust Co. of Nevada Inc. now owns 1,489 shares of the company’s stock valued at $47,000 after purchasing an additional 1,446 shares during the last quarter. Blue Trust Inc. increased its position in Option Care Health by 14.8% during the second quarter. Blue Trust Inc. now owns 2,931 shares of the company’s stock worth $81,000 after purchasing an additional 377 shares during the last quarter. Finally, International Assets Investment Management LLC grew its holdings in shares of Option Care Health by 3,029.7% during the 3rd quarter. International Assets Investment Management LLC now owns 2,848 shares of the company’s stock worth $91,000 after purchasing an additional 2,757 shares during the period. Hedge funds and other institutional investors own 98.05% of the company’s stock.

Insiders Place Their Bets

In other Option Care Health news, Director Harry M. Jansen Kraemer, Jr. bought 43,000 shares of the company’s stock in a transaction that occurred on Friday, November 8th. The stock was purchased at an average price of $22.54 per share, with a total value of $969,220.00. Following the transaction, the director now owns 326,334 shares in the company, valued at $7,355,568.36. This trade represents a 15.18 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. 0.64% of the stock is currently owned by insiders.

Option Care Health Price Performance

Option Care Health stock opened at $23.13 on Friday. Option Care Health, Inc. has a 12-month low of $21.39 and a 12-month high of $34.63. The firm’s 50-day moving average is $27.62 and its two-hundred day moving average is $29.10. The stock has a market capitalization of $3.94 billion, a P/E ratio of 19.44, a P/E/G ratio of 2.33 and a beta of 1.32. The company has a debt-to-equity ratio of 0.77, a current ratio of 1.73 and a quick ratio of 1.32.

Analyst Ratings Changes

Several research firms have recently commented on OPCH. The Goldman Sachs Group lowered Option Care Health from a “buy” rating to a “neutral” rating and lowered their price target for the stock from $38.00 to $27.00 in a research report on Monday, November 4th. Barrington Research decreased their target price on Option Care Health from $40.00 to $32.00 and set an “outperform” rating for the company in a research note on Thursday, October 31st. Jefferies Financial Group cut shares of Option Care Health from a “buy” rating to a “hold” rating and decreased their price target for the stock from $38.00 to $26.00 in a research note on Thursday, October 31st. Bank of America cut Option Care Health from a “buy” rating to a “neutral” rating and reduced their price target for the company from $43.00 to $29.00 in a report on Wednesday, October 30th. Finally, Truist Financial decreased their price target on Option Care Health from $41.00 to $34.00 and set a “buy” rating on the stock in a research note on Friday, November 1st. Three research analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $30.83.

Option Care Health Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.